News & Updates
Filter by Specialty:

Family history of CRC ups risk of adenoma, neoplasia
Individuals with a family history of colorectal cancer (CRC) are at greater risk of developing adenoma, nonadvanced adenoma (NAA), advanced adenoma (AA), and advanced neoplasia (AN), reveals a study.
Family history of CRC ups risk of adenoma, neoplasia
17 Mar 2025
Study reveals liver- and tumour-specific indicators against repeat TACE in HCC patients
Repeat transarterial chemoembolization (TACE) is not recommended for patients with hepatocellular carcinoma (HCC) who have persistent liver function deterioration after initial TACE, particularly if they have suboptimal baseline liver function or excessive tumour burden, according to researchers from the Chinese University of Hong Kong (CUHK).
Study reveals liver- and tumour-specific indicators against repeat TACE in HCC patients
14 Mar 2025
Treatment de-escalation safe in patients with ERBB2-positive early breast cancer and high TILs
De-escalation of chemotherapy dose and trastuzumab duration may not increase the risk of distant relapse or death in patients with ERBB2-positive (also referred to as HER2-positive) early breast cancer and tumour infiltrating lymphocyte (TIL) levels of ≥20 percent, according to a 10-year analysis of the phase III ShortHER trial.